Philadelphia, PA USA

Our News on Newswise

Wistar Scientists Discover How Key Proteins Segregate Vital Genetic Information during Mitosis

Noma10_larger.jpg

New research from The Wistar Institute has identified an interaction between proteins that provides a pivotal role in organizing chromosomes during mitosis so that vital genetic information gets passed on safely.
31-Jul-2015 4:00 PM EDT

The Wistar Institute and Rockland Immunochemicals Announce Partnership in Discovery and Research

DSC_0006_1.jpg

Trusted partners leverage Wistar Science.
13-Jul-2015 1:05 PM EDT

Treatment With PI3K Inhibitors May Cause Cancers to Become More Aggressive and Metastatic

DarioAltieri_2015.jpg

The enzyme PI3K appears to be exploited in almost every type of human cancer, making it the focus of considerable interest as a therapeutic target. However, PI3K inhibitors have only shown modest clinical activity. Now, new research The Wistar...
26-Jun-2015 11:00 AM EDT

Wistar Scientists Pinpoint Mutations Responsible for Ineffectiveness of 2014-2015 Flu Vaccine

ScottHensley.jpg

Viruses like influenza have the ability to mutate over time, and given that the flu vaccines administered during the 2014-2015 season were largely ineffective at preventing the spread of the flu, it appears the virus that recently circulated had...
23-Jun-2015 12:00 PM EDT

Wistar Scientists Discover “Highly Effective” New Biomarker for Lung Cancer

Scientists at The Wistar Institute have found a protein that circulates in the blood that appears to be more accurate at detecting non-small cell lung cancer (NSCLC) than currently available methods used for screening.
3-Jun-2015 9:05 AM EDT

Condensin II Complex Is “Master Controller” Behind DNA Structure Reorganization During Senescence

Ken-ichiNoma-small.jpg

Wistar Institute scientists have identified how a specific variant of a key protein complex found in human cells called condensin can reorganize a cell’s genetic architecture in such a way as to promote senescence, making it an important...
2-Jun-2015 2:00 PM EDT

Wistar Receives $5.6 Million Grant Renewal from Wellcome Trust to Develop Drug Against Cancers Caused by Epstein-Barr Virus

Lieberman_Messick.jpg

The Wistar Institute and London-based global charity Wellcome Trust announce that they have signed a follow-on funding agreement in support of ongoing research and development of a new class of drugs useful for treating cancers associated with...
19-May-2015 11:30 AM EDT

The Wistar Institute and Fox Chase Chemical Diversity Center Launch Alliance to Propel Early-Stage Discoveries

Heatherheadshot.jpg

Wistar and Fox Chase Chemical Diversity Center advance biomedical science one partnership at a time
5-May-2015 9:05 AM EDT

Our YouTube Videos